Metformin ameliorates olanzapine-induced insulin resistance via suppressing macrophage infiltration and inflammatory responses in rats

被引：25
作者：
Guo, Cuilian [1 ]
Liu, Jinxin [1 ]
Li, Huqun [2 ]
机构：
[1] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Otolaryngol Head & Neck Surg, Tongji Med Coll, Wuhan, Peoples R China
[2] Huazhong Univ Sci & Technol, Cent Hosp Wuhan, Dept Pharm, Tongji Med Coll, Wuhan 430014, Peoples R China
来源：
BIOMEDICINE & PHARMACOTHERAPY | 2021年 / 133卷
关键词：
Olanzapine; Metformin; Insulin resistance; Macrophage infiltration; Rats; WEIGHT-GAIN; METABOLIC SYNDROME; DOUBLE-BLIND; OBESITY; SCHIZOPHRENIA; DYSREGULATION; EXPRESSION; CELLS; POLARIZATION; DEFICIENCY;
D O I：
10.1016/j.biopha.2020.110912
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
Aims: The present study aimed to investigate the possible effects of metformin on the olanzapine-induced insulin resistance in rats. Methods: Rats were randomly divided into three groups: the control (Control) group, the olanzapine (Ola) group and the olanzapine + metformin (Ola + Met) group. Rats in the Ola group received olanzapine (8 mg/kg/day) intraperitoneally while rats in the Ola + Met group received olanzapine (8 mg/kg/day) intraperitoneally and metformin (300 mg/kg/day) orally for 8 weeks. Rats in the Control group received vehicle accordingly. Body weight and fasting blood glucose were recorded routinely. Inflammatory cytokines TNF-alpha, IL-6 and IL-1 beta and IL-10 were measured by ELISA. The gene expression of macrophages markers was examined by qPCR. The epididymal white adipose tissue, liver and skeletal muscle were also isolated for immunohistochemical analysis. Results: Olanzapine significantly induced body weight gain and insulin resistance compared to the control, which was markedly alleviated by metformin. Pro-inflammatory cytokines TNF-alpha, IL-6 and IL-1 beta were upregulated while the anti-inflammatory cytokine IL-10 was downregulated by olanzapine in plasma and epididymal white adipose tissue compared to the control, but not the liver and skeletal muscle. However, metformin co-administration significantly decreased the levels of TNF-alpha, IL-6 and IL-1 beta while increased the level of IL-10 in epididymal white adipose tissue compared to olanzapine-treated rats. Moreover, olanzapine treatment markedly increased the expression of the CD68 and the M1 macrophage markers while decreased the expression of the M2 macrophage markers in epididymal white adipose tissue in rats compared to the control. However, metformin co-treatment ameliorated the effects of olanzapine. Conclusions: Our results suggest that metformin alleviated olanzapine-induced insulin resistance possibly by suppressing the inflammatory responses mediated by macrophage infiltration and polarization in epididymal white adipose tissue.
引用
收藏
页数：9
相关论文
共 47 条
[1]   Tumor Necrosis Factor-Alpha: Role in Development of Insulin Resistance and Pathogenesis of Type 2 Diabetes Mellitus [J].
Akash, Muhammad Sajid Hamid ;
Rehman, Kanwal ;
Liaqat, Aamira .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2018, 119 (01) :105-110
[2]   Antipsychotic-induced weight gain in chronic and first-episode psychotic disorders -: A systematic critical reappraisal [J].
Alvarez-Jimenez, Mario ;
Gonzalez-Blanch, Cesar ;
Crespo-Facorro, Benedicto ;
Hetrick, Sarah ;
Rodriguez-Sanchez, Jose Manuel ;
Perez-Iglesias, Rocio ;
Vazquez-Barquero, Jose Luis .
CNS DRUGS, 2008, 22 (07) :547-562
[3]   IKK-β links inflammation to obesity-induced insulin resistance [J].
Arkan, MC ;
Hevener, AL ;
Greten, FR ;
Maeda, S ;
Li, ZW ;
Long, JM ;
Wynshaw-Boris, A ;
Poli, G ;
Olefsky, J ;
Karin, M .
NATURE MEDICINE, 2005, 11 (02) :191-198
[4]   Role of immune cells in obesity induced low grade inflammation and insulin resistance [J].
Asghar, Ambreen ;
Sheikh, Nadeem .
CELLULAR IMMUNOLOGY, 2017, 315 :18-26
[5]   Metformin for prevention of weight gain and insulin resistance with olanzapine:: A double-blind placebo-controlled trial [J].
Baptista, T ;
Martínez, J ;
Lacruz, A ;
Rangel, N ;
Beaulieu, S ;
Serrano, A ;
Arapé, Y ;
Martinez, M ;
de Mendoza, S ;
Teneud, L ;
Hernández, L .
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2006, 51 (03) :192-196
[6]   Metformin plus sibutramine for olanzapine-associated weight gain and metabolic dysfunction in schizophrenia:: A 12-week double-blind, placebo-controlled pilot study [J].
Baptista, Trino ;
Uzcategui, Euderruh ;
Rangel, Nairy ;
El Fakih, Yamily ;
Galeazzi, Tatiana ;
Beaulieu, Serge ;
de Baptista, Enma Araujo .
PSYCHIATRY RESEARCH, 2008, 159 (1-2) :250-253
[7]   Differential effects of 3 classes of antidiabetic drugs on olanzapine-induced glucose dysregulation and insulin resistance in female rats [J].
Boyda, Heidi N. ;
Procyshyn, Ric M. ;
Tse, Lurdes ;
Hawkes, Erin ;
Jin, Chen Helen ;
Pang, Catherine C. Y. ;
Honer, William G. ;
Barr, Alasdair M. .
JOURNAL OF PSYCHIATRY & NEUROSCIENCE, 2012, 37 (06) :407-415
[8]   Metabolic syndrome in schizophrenia: Differences between antipsychotic-naive and treated patients [J].
Chadda, Rakesh K. ;
Ramshankar, Prashanth ;
Deb, Koushik S. ;
Sood, Mamta .
JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS, 2013, 4 (03) :176-186
[9]   Gender-dependent consequences of chronic olanzapine in the rat: effects on body weight, inflammatory, metabolic and microbiota parameters [J].
Davey, Kieran J. ;
O'Mahony, Siobhain M. ;
Schellekens, Harriet ;
O'Sullivan, Orla ;
Bienenstock, John ;
Cotter, Paul D. ;
Dinan, Timothy G. ;
Cryan, John F. .
PSYCHOPHARMACOLOGY, 2012, 221 (01) :155-169
[10]  
Diabet Prevention Program Res Grp, 2005, DIABETES, V54, P1566
12345